Nurix Therapeutics NRIX
NASDAQ NRIX
$22.99 -0.35 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Return on Assets [ROA] (2020 - 2026)

Updated

Nurix Therapeutics' Return on Assets [ROA] came in at -58.27% for fiscal Q2 2026 (quarter ended May 31, 2026), down 23.90 percentage points from -34.36% a year earlier and down 13.67 percentage points from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025 (ended Nov 30, 2025), Nurix Therapeutics' Return on Assets [ROA] was -38.96%, down 1.19 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of -19.32 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Assets [ROA] was -37.77% in FY2024 (-0.50 pp), -37.27% in FY2023 (+3.10 pp), -40.37% in FY2022 (-13.53 pp) and -26.85% in FY2021 (-7.21 pp).
  • The fiscal Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] in data going back to fiscal Q4 2020.
  • Year-over-year, Return on Assets [ROA] has declined for four consecutive quarters, with an average year-over-year change of -2.33 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q1 2025 (a gain of 10.86 percentage points), and the weakest in fiscal Q2 2026 (a drop of 23.90 percentage points).
  • Business Quant data shows NRIX's Return on Assets [ROA] at -44.60% (Q1 2026), -43.69% (Q4 2025) and -43.95% (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Nurix Therapeutics 2.38 Bn 378.07 Mn - -58.27%
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 -58.27%
Feb 28, 2026 -44.60%
Nov 30, 2025 -43.69%
Aug 31, 2025 -43.95%
May 31, 2025 -34.36%
Feb 28, 2025 -32.45%
Nov 30, 2024 -32.73%
Aug 31, 2024 -34.54%
May 31, 2024 -40.06%
Feb 29, 2024 -43.32%
Nov 30, 2023 -43.37%
Aug 31, 2023 -45.14%
May 31, 2023 -43.69%
Feb 28, 2023 -45.38%
Nov 30, 2022 -41.17%
Aug 31, 2022 -40.14%
May 31, 2022 -37.13%
Feb 28, 2022 -29.62%
Nov 30, 2021 -24.16%
Aug 31, 2021 -19.67%
API Access

Nurix Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NRIX&period=max&api_key=YOUR_API_KEY